New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
12:19 EDTWMT, KO, RPRX, PRKR, QCOM, PAY, RFMD, SWKSOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday following a number of domestic economic reports. The averages dipped at the outset in a continuation of yesterday’s moderate sell-off, though the market found a level about a half hour into the session and has been range bound since that point... ECONOMIC EVENTS: In the U.S., initial jobless claims rose 20K to 362K last week, coming in above the consensus forecast for 355K claims. The headline consumer price index was flat in January, versus expectations for 0.1% increase, while the "core" rate climbed 0.3%, which was above the 0.2% forecast. Markit's "flash" purchasing managers' index for the U.S. for February came in at 55.2, versus forecasts for a 55.5 first look for the month. The Philadelphia Fed Manufacturing survey fell to -12.5, versus expectations for it to rise to +1.0. Existing home sales for January increased 0.4% to a 4.92M pace, versus an expected decline of 0.8%. The leading economic indicators rose 0.2% to 94.1 in January, in line with expectations. In Europe, the composite services and manufacturing PMI for the shared currency nations fell to 47.3 in February from 48.6 in January, missing forecasts for an improved reading... COMPANY NEWS: Wal-Mart (WMT) confirmed its February sales started off weak, as leaked in internal emails reported by Bloomberg last week. The telegraphed bad start was reflected in the company’s worse than expected forecast for the coming quarter, but earnings in the holiday quarter that just ended beat consensus. The company raised its dividend by 18% as well and shares of the Dow member reacted favorably, rising about 2.5% to lead the DJIA... Coca-Cola (KO), another Dow component, also increased its dividend by 10%, though investor reaction was more muted. Coke shares were up fractionally in midday trading after the announcement... MAJOR MOVERS: Among the notable gainers were ParkerVision (PRKR), which jumped 37% after the company said it received favorable patent in patent claim construction ruling in a suit with Qualcomm (QCOM), and Repros Therapeutics (RPRX), which rose 32% after it said the FDA recommended it complete its study of Androxal. Among the noteworthy losers was VeriFone (PAY), which sank 39% after the company's preliminary Q1 results and preliminary Q2 guidance fell below expectations and the stock was downgraded by at least five firms. Also lower were shares of several semiconductor makers, including RF Micro Devices (RFMD) and Skyworks Solutions (SWKS), which fell following downgrades at Raymond James and the announcement of a new class of chips from Qualcomm... INDICES: Near noon, the Dow was down 59.72, or 0.43%, to 13,867.82; the Nasdaq was down 29.41, or 0.93%, to 3,135.00; and the S&P 500 was down 9.25, or 0.61%, to 1,502.70.
News For WMT;KO;RPRX;PRKR;QCOM;PAY;RFMD;SWKS From The Last 14 Days
Check below for free stories on WMT;KO;RPRX;PRKR;QCOM;PAY;RFMD;SWKS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 18, 2014
08:48 EDTSWKSSkyworks price target raised to $65 from $55 at Oppenheimer
Oppenheimer increased its price target on Skyworks after the company reported stronger than expected results and guidance. The firm called the company's results and guidance "exemplary." It reiterates an Outperform rating on the shares.
08:23 EDTSWKSSkyworks price target raised to $60 from $50 at JMP Securities
Subscribe for More Information
08:01 EDTSWKSSkyworks price target raised to $55 form $51 at Canaccord
Subscribe for More Information
07:29 EDTSWKSSkyworks price target raised to $58 from $54 at Brean Capital
Subscribe for More Information
July 17, 2014
18:31 EDTRFMD, SWKSOn The Fly: After Hours Movers
Subscribe for More Information
16:58 EDTSWKSSkyworks sees Q4 EPS $1.00, consensus 87c
Sees Q4 revenue $680M, consensus $608.11M.
16:56 EDTSWKSSkyworks reports Q3 EPS 83c, consensus 80c
Subscribe for More Information
15:26 EDTSWKSNotable companies reporting after market close
Subscribe for More Information
06:19 EDTKOCoca-Cola to invest over $8.2B in Mexico over six years, WSJ reports
Coca-Cola Mexico President Francisco Crespo announced during a ceremony in Toluca, Mexico, that the company will invest over $8.2B in Mexico over the next six years along with its eight local bottlers, the Wall Street Journal reports. The investment comes despite a 12% tax Mexico has placed on full-calorie sodas, teas and juices. Reference Link
July 16, 2014
13:28 EDTRPRXRepros Therapeutics trial endpoints should be achieved, says Piper Jaffray
Piper Jaffray believes the endpoints selected for the Androxal Phase 3 studies for the treatment of secondary hypogonadism should be "readily achieved." Piper views the company's dialogue with the FDA as "very constructive" and reiterates an Overweight rating on Repros with a $26 price target.
11:29 EDTQCOMIntel hits 52-week high after results beat estimates
Subscribe for More Information
09:26 EDTRPRXRepros Therapeutics announces FDA confirmation of endpoints for Androxal
Repros Therapeutics announced it has received additional guidance from the FDA regarding primary endpoints for the two studies, ZA-304 and ZA-305, that it is currently conducting comparing Androxal to the leading approved testosterone gel and placebo. The FDA proposed three co-primary endpoints: Percentage change from baseline in sperm concentration comparing Androxal to the leading U.S. testosterone replacement therapy; proportion of men obtaining a testosterone in the normal range; percentage of men that exhibit sperm greater than or equal to 10M/mL at the end of 16 weeks of dosing and testosterone in the normal range, comparing Androxal to a testosterone gel as well as comparing Androxal to placebo. The primary endpoints and statistical analysis plan outlined for ZA-304 and ZA-305 below are being modified to comply with the FDA suggestions. The company believes the two studies are adequately powered to meet these endpoints.
July 15, 2014
18:18 EDTKOPepsiCo escalates operations in Myanmar, Nikkei reports
Subscribe for More Information
10:15 EDTSWKSSkyworks expect Q3 guidance of $622M vs. consensus of $606M, says Rosenblatt
Subscribe for More Information
08:10 EDTPRKRParkerVision to host ivnestor and analyst meeting
Subscribe for More Information
08:06 EDTSWKSSkyworks Q4 guidance poised to beat expectations, says Oppenheimer
Subscribe for More Information
07:50 EDTQCOMQualcomm estimates adjusted to reflect inventory transition, says Canaccord
Canaccord adjusted its estimates for Qualcomm to reflect an ongoing inventory transition in China from 3G to 4G devices. The firm continues to expect strong growth of smartphones, the upgrade to new air interface technologies, and strong market share gains to drive sales and earnings growth. Qualcomm shares are Buy rated with a $95 price target.
07:15 EDTKOIIR Holdings to hold a conference
14th Annual Shopper Insights in Action Conference to be held in Chicago on July 14-16.
06:11 EDTQCOMSamsung, HiSilicon to sell more handset solutions to vendors, DigiTimes says
Subscribe for More Information
05:53 EDTWMTStocks with implied volatility movement; CSCO WMT
Stocks with implied volatility movement; Cisco (CSCO) 23, Wal-Mart (WMT) 13 according to iVolatility.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use